Archives: Speakers

Mergime Behrami is a Senior Manager in Sales at Thermo Fisher Scientific, leading engagement with biotech customers across mainland Europe. Since joining the company in 2016, Mergime has built a career spanning project management and business development, with a strong focus on delivering consultative solutions to biotech partners. Before Thermo Fisher, Mergime gained experience in early-phase clinical trial management at Parexel and in quality functions at Celgene.

Andreas is Director of Partnerships at Ledidi, where he works with international medtech, diagnostics and academic hospital partners on clinical research, registries and clinical audits. He has also been closely involved in the development and launch of Ledidi Trials for regulatory-grade clinical trials and interventional studies.

Dr. Xiong Hanyu holds a Ph.D. from the University of Science and Technology of China (USTC). Currently serving as a Senior Fire Safety Engineer at CRRC Zhuzhou Locomotive Co., Ltd., she has built an extensive career specializing in the fire safety design, risk assessment, and technical management of railway vehicles. She notably spearheaded the fire protection design for the Modula platform, a modular locomotive developed for the European market, ensuring compliance with rigorous international safety standards. Her current research focuses on the safety applications of new energy power systems in rolling stock, as well as passenger evacuation security. She is currently a lead researcher for the “Key Technologies for New Energy Hybrid Locomotives” initiative in Hunan Province, China, driving the safety standards for the next generation of sustainable rail transit.

Duncan is the Managing Director of Global Semiconductor Research and Managing Director of Global Telecom Research, Director of TMT Research for Deloitte Canada, and a member of Deloitte’s US Center for Technology, Media & Telecommunications (TMT Center). He is a globally recognized expert on predicting the future of consumer and enterprise technology, media & telecommunications. He has been co-author of Deloitte Global’s annual Predictions report on trends in TMT since 2008. He meets with hundreds of tech, media, and telecom companies globally each year, and incorporates their insights into his work. He presents to companies and at conferences, has a high-profile media presence, and is frequently interviewed on the future of pretty much everything.

Duncan has 35 years of experience in the TMT industry. In his previous life as a portfolio manager, he made investments in the tech and telecom sector, and won the Canadian Technology Fund Manager of the Year award in its inaugural year. He deployed a cumulative $2 billion of capital into global TMT markets, in public and private companies.

Constantyn brings over 19 years of experience in the energy sector, specializing in natural gas projects in both a technical and commercial capacity. His expertise particularly focuses on leading projects through all pre-FID stages, where he has successfully contributed to projects of varying size, including large-scale, multi-billion-dollar infrastructure initiatives. He holds a Double BS in Chemical Engineering & Material Science from UC Berkeley and an MBA from UT Austin McCombs School of Business. Constantyn currently leads all datacenter-related power projects for Pacifico Energy, and in particular, has spearheaded the development of the GW Ranch project.

Hermann is currently Senior Director Global Logistics capabilities at Bristol Myers Squibb and responsible for the Global Strategy, Digital roadmap and Process and System solutions implementation as well as for the Global SAP S4 HANA implementation. Previously he served as the Region Head of EMEA Logistics for Johnson and Johnson and has more than 25 years of experience within the FMCG and Pharma industry. He designed and implemented multiple Industry leading Supply Chain solutions that had been awarded as industry best practice externally and reset the Supply chain standards within the healthcare industry. He is a strong believer in holistic optimization of supply chains to drive value creation while ensuring the Patient and Customer Experience is at the forefront of everything we do.

• Expert in information management and large language model applications
• Manager, Digital Transformation in Supply Chain Management (Pharma)
• Over 30 years of experience in a global industrial environment
• Extensive international track record across the USA, Vietnam, China, and Europe
• Recipient of the 2017 Supply Chain Breakthrough of the Year Award (Crop area)
• Bicultural: French–German background
• Conference speaker on digital transformation, artificial intelligence, and innovation methods

Chitra Sharma is a high-impact biotechnology executive with over 25 years of experience architecting product lifecycles from early-stage development through successful NDA/BLA approvals. A specialist in CMC and global Quality operations, she has pioneered regulatory and development strategies, working for industry titans including Genentech, Roche Bioscience, Cor Therapeutics and Vivus.
Currently, as SVP of Development at Scribe Therapeutics, she integrates breakthrough innovation with operational excellence.

Chitra’s expertise spans a sophisticated portfolio of CRISPR, Cell and Gene Therapy, Biologics and small molecules. Over 13 years as a founder and consultant, she served as a premier bridge between scientific discovery and commercial viability for both Fortune 500 firms and agile startups.
A pragmatic leader with deep technical mastery, Chitra is defined by her ability to scale global operations and build high-performing, compliant organizations that navigate the complexities of international drug development.

Akvile is a Solution Sales Specialist at Medidata, where she works with executive stakeholders to shape enterprise-level data experience strategies for clinical development, supporting sponsors as they transition from siloed outsourcing models to integrated, evidence-driven operating frameworks. Drawing on experience across academia, Medtech and imaging CROs, Akvile engages at the intersection of platform architecture, data governance, and outsourcing strategy, advising clinical operations leaders how data connectivity decisions influence scalability, oversight, and long-term value creation in clinical development.